Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jean Boutonnat

Showing results (1-10 of 57) with videos related to

Pageof 6
Sort By:
Current Drug Targets|April 10, 2009
Chalcones derivatives acting as cell cycle blockers: potential anti cancer drugs?Ahcene Boumendjel, Xavier Ronot, Jean Boutonnat
Annales De Pathologie|November 6, 2009
[Urinary cytology and polyomavirus infection: a major stake for patients]Jean Boutonnat, Nicole Pinel, Bénédicte Janbon
Annales De Pathologie|November 7, 2012
[Specific aspects of immunocytochemistry]Monique Courtade-Saïdi, Jean Boutonnat, Sandrine Heiny
Medicinal Research Reviews|December 15, 2007
Flavonoids as RTK inhibitors and potential anticancer agentsFlorence Teillet, Ahcene Boumendjel, Jean Boutonnat, et al.
In Vivo (Athens, Greece)|March 31, 2005
Intra-serous haematopoiesisBrigitte Vaunois, Michele Breyton, Daniel Seigneurin, et al.
The Journal of Infectious Diseases|November 19, 2003
Severe clinical forms of cytochrome b-negative chronic granulomatous disease (X91-) in 3 brothers with a point mutation in the promoter region of CYBBMarie José Stasia, Jean-Paul Brion, Jean Boutonnat, et al.
Pathology, Research and Practice|September 10, 2020
The transcriptional factors CDX2 and FOXA1 in chordomasMaroa Dridi, Jean Boutonnat, Jean Marc Dumollard, et al.
Comptes Rendus Biologies|August 7, 2002
Modelling of cell proliferation: nuclear versus membrane labellingMagali Barbier, Jean-Fabien Laurier, Daniel Seigneurin, et al.
Annals of Diagnostic Pathology|May 14, 2021
Patterns of brachyury expression in chordomasMaroa Dridi, Jean Boutonnat, Jean Marc Dumollard, et al.
American Journal of Clinical Pathology|February 25, 2021
INSM1 Expression in ChordomasMaroa Dridi, Jean Boutonnat, Jean Marc Dumollard, et al.
Pageof 6

Showing results (1-10 of 57) with videos related to

Sort By:
Pageof 6
Current Drug Targets|April 10, 2009
Chalcones derivatives acting as cell cycle blockers: potential anti cancer drugs?Ahcene Boumendjel, Xavier Ronot, Jean Boutonnat
Annales De Pathologie|November 6, 2009
[Urinary cytology and polyomavirus infection: a major stake for patients]Jean Boutonnat, Nicole Pinel, Bénédicte Janbon
Annales De Pathologie|November 7, 2012
[Specific aspects of immunocytochemistry]Monique Courtade-Saïdi, Jean Boutonnat, Sandrine Heiny
Medicinal Research Reviews|December 15, 2007
Flavonoids as RTK inhibitors and potential anticancer agentsFlorence Teillet, Ahcene Boumendjel, Jean Boutonnat, et al.
In Vivo (Athens, Greece)|March 31, 2005
Intra-serous haematopoiesisBrigitte Vaunois, Michele Breyton, Daniel Seigneurin, et al.
The Journal of Infectious Diseases|November 19, 2003
Severe clinical forms of cytochrome b-negative chronic granulomatous disease (X91-) in 3 brothers with a point mutation in the promoter region of CYBBMarie José Stasia, Jean-Paul Brion, Jean Boutonnat, et al.
Pathology, Research and Practice|September 10, 2020
The transcriptional factors CDX2 and FOXA1 in chordomasMaroa Dridi, Jean Boutonnat, Jean Marc Dumollard, et al.
Comptes Rendus Biologies|August 7, 2002
Modelling of cell proliferation: nuclear versus membrane labellingMagali Barbier, Jean-Fabien Laurier, Daniel Seigneurin, et al.
Annals of Diagnostic Pathology|May 14, 2021
Patterns of brachyury expression in chordomasMaroa Dridi, Jean Boutonnat, Jean Marc Dumollard, et al.
American Journal of Clinical Pathology|February 25, 2021
INSM1 Expression in ChordomasMaroa Dridi, Jean Boutonnat, Jean Marc Dumollard, et al.
Pageof 6